KYMR — KYMERA THERAPEUTICS INC

Ownership history in Engineers Gate Manager LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in KYMERA THERAPEUTICS INC (KYMR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2024 Q1)
Avg. % of fund
0.01%
First filed
2022 Q3
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 6,475 -14,519 -69.2% 0.00% $366K $56.60
2024 Q1 REDUCED 20,994 -4,129 -16.4% 0.02% $844K $40.20
2023 Q4 ADDED 25,123 +14,202 +130.0% 0.02% $640K $25.46
2022 Q3 INITIATED 10,921 — — 0.01% $238K $21.77
% of Fund (quarterly)    KYMR price (monthly, adj. close)

Other funds also holding KYMR

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 41.91% BVF INC/IL 3Y 7Y 14.41% Siren, L.L.C. 7.63% Avoro Capital Advisors LLC 3Y 7Y 5.72% Octagon Capital Advisors LP 3Y 5.05% Monashee Investment Management LLC 3Y 7Y 4.38% BAKER BROS. ADVISORS LP 3Y 7Y 3.94% Commodore Capital LP 3Y 3.88% Eagle Health Investments LP 3Y 2.33% Patient Square Capital LP 3Y 2.32%
← Back to Engineers Gate Manager LP Holdings